Kevin Charles Gorman

Companies

• Xencor IncBoard member Apr 17, 2017 to now¹
• Neurocrine BiosciencesBoard member Feb 29, 2008 to now²
• Neurocrine BiosciencesChief executive officer Feb 14, 2008 to Feb 15, 2024³
• Neurocrine BiosciencesPresident Feb 14, 2008 to Dec 23, 2016³
• Neurocrine BiosciencesSr. VP, Business Dev. Jan 23, 2006 to Oct 26, 2007⁴
• Neurocrine BiosciencesChief operating officer Jan 16, 2007 to Jan 16, 2007⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Neurocrine Biosciences NBIX517,797 shares⁶$71.1M at $137.36Sep 11, 2026
• XXencor Inc XNCR21,680 shares⁷$502.5K at $23.18Jun 16, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 11, 2026Shares withheld for tax 7,839 shares at $156.22 of Neurocrine Biosciences⁶
• Sep 11, 2026Granted 14,343 shares of Neurocrine Biosciences⁶
• Jun 16, 2026Granted 10,302 shares of Xencor Inc⁷
• Jun 15, 2026Sold 7,527 shares at $12.31 of Xencor Inc⁸
• May 19, 2026Sold 245,088 shares at $154.33 of Neurocrine Biosciences⁹
• May 19, 2026Exercised options 205,088 shares at $43.24 of Neurocrine Biosciences⁹
• Feb 13, 2026Shares withheld for tax 34,380 shares at $124.12 of Neurocrine Biosciences¹⁰
• Feb 13, 2026Granted 63,724 shares of Neurocrine Biosciences¹⁰
• Feb 13, 2026Shares withheld for tax 2,901 shares at $124.12 of Neurocrine Biosciences¹⁰
• Feb 13, 2026Exercised options 5,377 shares of Neurocrine Biosciences¹⁰
• Feb 13, 2026Shares withheld for tax 3,024 shares at $124.12 of Neurocrine Biosciences¹⁰
• Feb 13, 2026Exercised options 5,604 shares of Neurocrine Biosciences¹⁰
• Jan 31, 2026Shares withheld for tax 2,845 shares at $136.06 of Neurocrine Biosciences¹¹
• Jan 31, 2026Exercised options 5,142 shares of Neurocrine Biosciences¹¹
• Aug 7, 2025Sold 106,322 shares at $126.41 of Neurocrine Biosciences¹²
• Aug 7, 2025Exercised options 106,322 shares at $35.99 of Neurocrine Biosciences¹²
• Jun 16, 2025Sold 3,173 shares at $9.22 of Xencor Inc¹³
• Jun 12, 2025Granted 13,686 shares of Xencor Inc¹³
• May 27, 2025Sold 9,613 shares at $120.38 of Neurocrine Biosciences¹⁴
• Feb 13, 2025Sold 3,012 shares at $116.68 of Neurocrine Biosciences¹⁵
• Feb 13, 2025Exercised options 5,603 shares of Neurocrine Biosciences¹⁵
• Feb 13, 2025Sold 2,832 shares at $116.69 of Neurocrine Biosciences¹⁵
• Feb 13, 2025Exercised options 5,376 shares of Neurocrine Biosciences¹⁵
• Feb 10, 2025Sold 2,274 shares at $118.37 of Neurocrine Biosciences¹⁶
• Feb 8, 2025Exercised options 4,318 shares of Neurocrine Biosciences¹⁶